Treatment of Breast Cancer With Antibodies Against DR4 and DR5 Receptors in Combination With Chemotherapy

doi 10.21236/ada418338
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Phytosphingosine in Combination With TRAIL Sensitizes Cancer Cells to TRAIL Through Synergistic Up-Regulation of DR4 and DR5

Oncology Reports
MedicineCancer ResearchOncology
2007English

Notch Inhibition Restores TRAIL-mediated Apoptosis via AP1-dependent Upregulation of DR4 and DR5 TRAIL Receptors in MDA-MB-231 Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Optimal Sequences and Combination of Chemotherapy and Monoclonal Antibodies in the Treatment of Patients With Metastatic Colorectal Cancer

Malignant tumours
2018English

Combination Chemotherapy in Metastatic Breast Cancer

BMJ
1977English

Combination Chemotherapy in Metastatic Breast Cancer

InPharma
1977English

Treatment With Cisplatin and Etoposide Chemotherapy in Patient With Metastatic Breast Cancer

Journal of Breast Disease
2017English

Survival in Advanced Breast Cancer Combination Chemotherapy Improves Outlook

BMJ
1994English

Chemotherapy in Combination With Bevacizumab in Breast Cancer. Results of the Observational Study in Daily Clinical Practice

Malignant tumours
2017English

CAF vs. CMF Combination Chemotherapy in Advanced Breast Cancer Patients

International Journal of Science and Research (IJSR)
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy